-
Something wrong with this record ?
The chromatin landscape at the HIV-1 provirus integration site determines viral expression
G. Vansant, HC. Chen, E. Zorita, K. Trejbalová, D. Miklík, G. Filion, Z. Debyser,
Language English Country Great Britain
Document type Journal Article, Research Support, Non-U.S. Gov't
NLK
Directory of Open Access Journals
from 2005
Free Medical Journals
from 1996
PubMed Central
from 1974
Europe PubMed Central
from 1974
Open Access Digital Library
from 1996-01-01 to 2030-12-31
Open Access Digital Library
from 1974-01-01
Open Access Digital Library
from 1996-01-01
Open Access Digital Library
from 1996-01-01
Medline Complete (EBSCOhost)
from 1996-01-01
Oxford Journals Open Access Collection
from 1996-01-01
ROAD: Directory of Open Access Scholarly Resources
from 1974
PubMed
32597987
DOI
10.1093/nar/gkaa536
Knihovny.cz E-resources
- MeSH
- Cell Line MeSH
- Chromatin metabolism MeSH
- Histones metabolism MeSH
- HIV-1 drug effects genetics metabolism MeSH
- HIV Integrase Inhibitors pharmacology MeSH
- Virus Integration * drug effects MeSH
- Humans MeSH
- Intercellular Signaling Peptides and Proteins MeSH
- Proviruses genetics MeSH
- Gene Expression Regulation, Viral * drug effects MeSH
- RNA, Viral metabolism MeSH
- Gene Silencing * MeSH
- Check Tag
- Humans MeSH
- Publication type
- Journal Article MeSH
- Research Support, Non-U.S. Gov't MeSH
HIV-1 persists lifelong in memory cells of the immune system as latent provirus that rebounds upon treatment interruption. Therefore, the latent reservoir is the main target for an HIV cure. Here, we studied the direct link between integration site and transcription using LEDGINs and Barcoded HIV-ensembles (B-HIVE). LEDGINs are antivirals that inhibit the interaction between HIV-1 integrase and the chromatin-tethering factor LEDGF/p75. They were used as a tool to retarget integration, while the effect on HIV expression was measured with B-HIVE. B-HIVE tracks insert-specific HIV expression by tagging a unique barcode in the HIV genome. We confirmed that LEDGINs retarget integration out of gene-dense and actively transcribed regions. The distance to H3K36me3, the marker recognized by LEDGF/p75, clearly increased. LEDGIN treatment reduced viral RNA expression and increased the proportion of silent provirus. Finally, silent proviruses obtained after LEDGIN treatment were located further away from epigenetic marks associated with active transcription. Interestingly, proximity to enhancers stimulated transcription irrespective of LEDGIN treatment, while the distance to H3K36me3 only changed after treatment with LEDGINs. The fact that proximity to these markers are associated with RNA expression support the direct link between provirus integration site and viral expression.
References provided by Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc20024823
- 003
- CZ-PrNML
- 005
- 20201222153550.0
- 007
- ta
- 008
- 201125s2020 xxk f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.1093/nar/gkaa536 $2 doi
- 035 __
- $a (PubMed)32597987
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a xxk
- 100 1_
- $a Vansant, Gerlinde $u Laboratory for Molecular Virology and Gene Therapy, Department of Pharmaceutical and Pharmacological Sciences, KU Leuven, Leuven, Flanders, Belgium.
- 245 14
- $a The chromatin landscape at the HIV-1 provirus integration site determines viral expression / $c G. Vansant, HC. Chen, E. Zorita, K. Trejbalová, D. Miklík, G. Filion, Z. Debyser,
- 520 9_
- $a HIV-1 persists lifelong in memory cells of the immune system as latent provirus that rebounds upon treatment interruption. Therefore, the latent reservoir is the main target for an HIV cure. Here, we studied the direct link between integration site and transcription using LEDGINs and Barcoded HIV-ensembles (B-HIVE). LEDGINs are antivirals that inhibit the interaction between HIV-1 integrase and the chromatin-tethering factor LEDGF/p75. They were used as a tool to retarget integration, while the effect on HIV expression was measured with B-HIVE. B-HIVE tracks insert-specific HIV expression by tagging a unique barcode in the HIV genome. We confirmed that LEDGINs retarget integration out of gene-dense and actively transcribed regions. The distance to H3K36me3, the marker recognized by LEDGF/p75, clearly increased. LEDGIN treatment reduced viral RNA expression and increased the proportion of silent provirus. Finally, silent proviruses obtained after LEDGIN treatment were located further away from epigenetic marks associated with active transcription. Interestingly, proximity to enhancers stimulated transcription irrespective of LEDGIN treatment, while the distance to H3K36me3 only changed after treatment with LEDGINs. The fact that proximity to these markers are associated with RNA expression support the direct link between provirus integration site and viral expression.
- 650 _2
- $a buněčné linie $7 D002460
- 650 _2
- $a chromatin $x metabolismus $7 D002843
- 650 12
- $a regulace exprese virových genů $x účinky léků $7 D015967
- 650 12
- $a umlčování genů $7 D020868
- 650 _2
- $a inhibitory HIV-integrasy $x farmakologie $7 D019428
- 650 _2
- $a HIV-1 $x účinky léků $x genetika $x metabolismus $7 D015497
- 650 _2
- $a histony $x metabolismus $7 D006657
- 650 _2
- $a lidé $7 D006801
- 650 _2
- $a mezibuněčné signální peptidy a proteiny $7 D036341
- 650 _2
- $a proviry $x genetika $7 D011533
- 650 _2
- $a RNA virová $x metabolismus $7 D012367
- 650 12
- $a integrace viru $x účinky léků $7 D016662
- 655 _2
- $a časopisecké články $7 D016428
- 655 _2
- $a práce podpořená grantem $7 D013485
- 700 1_
- $a Chen, Heng-Chang $u Center for Genomic Regulation (CRG), The Barcelona Institute of Science and Technology, Barcelona, Catalunya, Spain.
- 700 1_
- $a Zorita, Eduard $u Center for Genomic Regulation (CRG), The Barcelona Institute of Science and Technology, Barcelona, Catalunya, Spain.
- 700 1_
- $a Trejbalová, Katerina $u Institute of Molecular Genetics, Czech Academy of Sciences, Videnska, Prague, Czech Republic.
- 700 1_
- $a Miklík, Dalibor $u Institute of Molecular Genetics, Czech Academy of Sciences, Videnska, Prague, Czech Republic.
- 700 1_
- $a Filion, Guillaume $u Center for Genomic Regulation (CRG), The Barcelona Institute of Science and Technology, Barcelona, Catalunya, Spain. University Pompeu Fabra, Barcelona, Catalunya, Spain.
- 700 1_
- $a Debyser, Zeger $u Laboratory for Molecular Virology and Gene Therapy, Department of Pharmaceutical and Pharmacological Sciences, KU Leuven, Leuven, Flanders, Belgium.
- 773 0_
- $w MED00003554 $t Nucleic acids research $x 1362-4962 $g Roč. 48, č. 14 (2020), s. 7801-7817
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/32597987 $y Pubmed
- 910 __
- $a ABA008 $b sig $c sign $y a $z 0
- 990 __
- $a 20201125 $b ABA008
- 991 __
- $a 20201222153547 $b ABA008
- 999 __
- $a ok $b bmc $g 1598968 $s 1115509
- BAS __
- $a 3
- BAS __
- $a PreBMC
- BMC __
- $a 2020 $b 48 $c 14 $d 7801-7817 $e 20200820 $i 1362-4962 $m Nucleic acids research $n Nucleic Acids Res $x MED00003554
- LZP __
- $a Pubmed-20201125